Researchers have tracked how the COVID-19 virus mutates long term, revealing patterns that could help predict the emergence of future variants. In the early days of the COVID-19 pandemic, as the world ...

Detection of common cold coronaviruses (ccCoVs) decreased by approximately half after the widespread SARS-CoV-2 exposure and COVID-19 vaccination, whereas detection of respiratory syncytial virus (RSV ...

A pill called ensitrelvir is the first drug shown to effectively reduce infection after exposure to SARS-CoV-2.

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The virologist had recently started an independent group at the University of Tokyo ...

A specialized lab at the University of Calgary is reopening to develop research into treatments and vaccines for COVID-19. The U of C's Biosafety Level 3 (BSL-3) lab, which is located in the Snyder ...

Researchers have discovered that SARS-CoV-2, the virus that causes COVID-19, may be changing crucial white blood cells called neutrophils so that instead of working to destroy pathogens, they instead ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

Brigham researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms. A persistent ...

The RNA-based Nipah virus, which causes acute respiratory illness and fatal encephalitis, can be transmitted from fruit bats to humans directly or indirectly via pigs or horses. Researchers at Wuhan ...